Neumora Therapeutics Inc (NASDAQ: NMRA) is -91.13% lower on its value in year-to-date trading and has touched a low of $0.90 and a high of $17.19 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NMRA stock was last observed hovering at around $0.91 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.94, the stock is -22.00% and -39.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing 2.97% at the moment leaves the stock -89.01% off its SMA200. NMRA registered -93.25% loss for a year compared to 6-month loss of -92.88%. The firm has a 50-day simple moving average (SMA 50) of $1.55256 and a 200-day simple moving average (SMA200) of $8.553515.
The stock witnessed a -33.30% gain in the last 1 month and extending the period to 3 months gives it a -91.50%, and is -13.72% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.56% over the week and 9.14% over the month.
Neumora Therapeutics Inc (NMRA) has around 110 employees, a market worth around $152.33M and $0.00M in sales. Distance from 52-week low is 4.48% and -94.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-84.92%).
The EPS is expected to grow by 4.29% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
182.0 institutions hold shares in Neumora Therapeutics Inc (NMRA), with institutional investors hold 99.33% of the company’s shares. The shares outstanding are 161.71M, and float is at 56.00M with Short Float at 23.03%. Institutions hold 71.99% of the Float.
The top institutional shareholder in the company is FMR LLC with over 8.62 million shares valued at $84.76 million. The investor’s holdings represent 5.4235 of the NMRA Shares outstanding. As of 2024-06-30, the second largest holder is SOFTBANK GROUP CORP. with 7.65 million shares valued at $75.17 million to account for 4.8099 of the shares outstanding. The other top investors are T. ROWE PRICE INVESTMENT MANAGEMENT, INC. which holds 5.1 million shares representing 3.2086 and valued at over $50.14 million, while BLACKROCK INC. holds 2.8955 of the shares totaling 4.6 million with a market value of $45.25 million.
Neumora Therapeutics Inc (NMRA) Insider Activity
Neumora Therapeutics Inc disclosed in a document filed with the SEC on Feb 18 ’25 that BERNS PAUL L sold a total of 13,871 shares of the company’s common stock. The trade occurred on Feb 18 ’25 and was made at $1.69 per share for $23468.0. Following the transaction, the insider now directly holds 7.41 million shares of the NMRA stock.
Still, SEC filings show that on Feb 18 ’25, Milligan Michael Lee disposed off 1,978 shares at an average price of $1.69 for $3351.0. The insider now directly holds 22,470 shares of Neumora Therapeutics Inc (NMRA).
